for medicines and diagnostics, announced Tuesday it has signed a deal with Vertex Pharmaceuticals, a biotech heavyweight best known for its cystic fibrosis therapies, to develop new treatments for genetic diseases delivered directly into the body, signaling more mainstream medical use of gene therapy after years of setbacks....
While gene therapy—a potentially curative treatment replacing faulty genes with healthy ones—has technically been possible for decades, it has typically not been precise enough to use clinically, something Crispr changes. David Altshuler, Vertex’s chief scientific officer, said Mammoth’s ultra-small Crispr systems will give the company “another set of tools to tackle many of the diseases we’re interested in” by directly editing genes inside patients. Crispr, standing for “clustered regularly interspaced short palindromic repeats,” is a powerful set of gene-editing tools derived from the immune systems of bacteria.
Congrats 🎉 mammothbiosci JLABS
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Mirror Celeb - 🏆 476. / 51 Read more »
Source: WSJ - 🏆 98. / 63 Read more »
Biotech Cellino raising $75 million for stem cell therapiesEXCLUSIVE: Rising biotech Cellino is raising $75 million to to make it easier to produce stem cells with AI 独家报道:瑞星生物技术公司Cellino正在筹集7500万美元,以使人工智能更容易生产干细胞
Source: BusinessInsider - 🏆 729. / 51 Read more »
Source: Variety - 🏆 108. / 63 Read more »
Source: PsychToday - 🏆 714. / 51 Read more »
Source: TheCut - 🏆 720. / 51 Read more »